D. E. Shaw & Co., Inc. Standard Biotools Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.05 $378,288 - $607,251	-199,099 Reduced 57.93%	144,598 $419,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $348,104 - $606,223	-236,806 Reduced 40.79%	343,697 $663,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.24 $268,724 - $463,032	-206,711 Reduced 26.26%	580,503 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$0.93 - $1.52 $18,540 - $30,302	-19,936 Reduced 2.47%	787,214 $921,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $90,074 - $168,685	-81,886 Reduced 9.21%	807,150 $888,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $94,411 - $235,437	59,007 Added 7.11%	889,036 $1.42 Million
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $172,496 - $243,959	-61,606 Reduced 6.91%	830,029 $2.98 Million
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $371,813 - $627,883	102,428 Added 12.98%	891,635 $3.5 Million
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $431,623 - $581,514	78,477 Added 11.04%	789,207 $5.2 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $750,183 - $1.1 Million	172,456 Added 32.04%	710,730 $4.38 Million
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $601,842 - $1.08 Million	-152,752 Reduced 22.11%	538,274 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $2.16 Million - $3.42 Million	395,827 Added 134.09%	691,026 $4.15 Million
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $3.72 Million - $9.78 Million	-856,072 Reduced 74.36%	295,199 $2.19 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $1.33 Million - $3.81 Million	720,550 Added 167.29%	1,151,271 $4.62 Million
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $962,815 - $3.38 Million	-776,464 Reduced 64.32%	430,721 $1.09 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $274,413 - $610,867	119,310 Added 10.97%	1,207,185 $4.2 Million
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $2.49 Million - $6.55 Million	538,869 Added 98.15%	1,087,875 $5.04 Million
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $4.42 Million - $5.45 Million	-384,683 Reduced 41.2%	549,006 $6.76 Million
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $6.04 Million - $10.2 Million	712,728 Added 322.56%	933,689 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$7.18 - $8.83 $162,713 - $200,105	-22,662 Reduced 9.3%	220,961 $1.91 Million
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $299,646 - $422,643	50,616 Added 26.22%	243,623 $1.83 Million
Q2 2018 Aug 14, 2018	BUY	$4.86 - $6.24 $269,127 - $345,546	55,376 Added 40.24%	193,007 $1.15 Million
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $206,660 - $286,449	35,941 Added 35.34%	137,631 $804,000
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $222,826 - $322,248	-49,961 Reduced 32.94%	101,690 $599,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $538,361 - $832,563	151,651	151,651 $764,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account